Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Although Saxenda
Although Saxenda is the first generic GLP-1 to hit the US market, its sales will likely be overshadowed by next-gen drugs such as Wegovy and Zepbound
D3S-001 Receives
D3S-001 Receives FDA Breakthrough Therapy, Orphan Drug Designations in Select KRAS G12C-Mutant Solid Tumors
FDA approves mRNA
FDA approves mRNA vaccines for new Covid-19 season amid political tension
Lilly links up with JD Health
Lilly links up with JD Health for DTC obesity, diabetes drug sales in China
Rumour
Rumour partly confirmed as AbbVie acquires Gilgamesh drug
FDA 483
FDA 483 Cites Contamination and Safety Issues at Novo Plant
Rusfertide
Rusfertide Receives Breakthrough Therapy Designation for Treatment of Erythrocytosis in Patients with Polycythemia Vera
Daiichi Sankyo and AstraZeneca’s
Daiichi Sankyo and AstraZeneca’s Datroway receives approval in China
Pfizer says
Pfizer says it couldn't have warned about tumor risk in Depo-Provera lawsuits
Swedish startup
Swedish startup secures €2.3M seed funding to boost AI monitoring tools for preclinical research
Merck Valuation in Focus
Merck Valuation in Focus After FDA Breakthrough Therapy Designation for Lung Cancer Drug
UK pharma drug price
UK pharma drug price talks break down as industry fails to lower discount rate
28
29
30
31
32
33
34
35
36
